Register for our S/EIS Fund

We are back on the virtual couch with Jennifer Petter, one of the most successful Boston based scientific entrepreneurs who is a key part of the management team that sold Avila to Celgene (now part of BMS) for $565M.

Jennifer was joined by Ros Deegan a British born and trained, Ros has spent a significant amount of her time in the USA most recently she established and led UK-based Bicycle Therapeutics US subsidiary, supporting the series B fund raise and negotiating significant transactions with AstraZeneca ($1B+ potential).

The panelists
Rosamond Deegan CEO at Omass Therapeutics

Rosamond established UK-based Bicycle Therapeutics US subsidiary, supporting the series B fund raise and negotiating significant transactions with AstraZeneca ($1B+ potential), Bioverativ ($14.2M upfront, multi-million dollar potential) and Cancer Research UK.

Jennifer Petter Founder at Arrakis Therapeutics

One of the most successful Boston based scientific entrepreneurs having been a key part of the management team that sold Avila to Celgene.

Sunil Shah CEO (Moderator)

Sunil is the CEO and Co-Founder of o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation.

Register for Invitations